EVOK (Evoke Pharma) Institutional Ownership : 14.70% (As of Mar. 26, 2025)

View and export this data going back to 2013. Start your Free Trial

What is Evoke Pharma Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Evoke Pharma's institutional ownership is 14.70%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Evoke Pharma's Insider Ownership is 47.03%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Evoke Pharma's Float Percentage Of Total Shares Outstanding is 99.73%.

Evoke Pharma Institutional Ownership Historical Data

The historical data trend for Evoke Pharma's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evoke Pharma Institutional Ownership Chart

Evoke Pharma Historical Data

The historical data trend for Evoke Pharma can be seen below:

	2024-05-31	2024-06-30	2024-07-31	2024-08-31	2024-09-30	2024-10-31	2024-11-30	2024-12-31	2025-01-31	2025-02-28
Institutional Ownership	0.42	0.71	0.71	0.63	0.44	0.58	0.30	0.70	0.70	0.70

Evoke Pharma Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Evoke Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Evoke Pharma Inc (NAS:EVOK) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

N/A

Address

420 Stevens Avenue, Suite 230, Solana Beach, CA, USA, 92075

Website

https://www.evokepharma.com

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

Executives

Vickie S Reed	director	TORREYPINES THERAPEUTICS, INC., 11085 NORTH TORREY PINES RD, STE 300, LA JOLLA CA 92037
David A Gonyer	director, officer: President and CEO	C/O EVOKE PHARMA, INC., 505 LOMAS SANTA FE DRIVE, SOLANA BEACH CA 92075
Matthew J D'onofrio	officer: Exec VP, Chief Bus. Officer	C/O EVOKE PHARMA, INC., 505 LOMAS SANTA FE DRIVE, SOLANA BEACH CA 92075
Lvp Gp Iii, Llc	10 percent owner	ONE EMBARCADERO CENTER SUITE 4050, SAN FRANCISCO CA 94111
Kenneth J Widder	director, 10 percent owner	10070 BARNES CANYON ROAD, SAN DIEGO CA 92121
Dp Vii Associates Lp	10 percent owner	ONE PALMER SQ, STE 515, PRINCETON NJ 08542
Domain Parters Vii L P	10 percent owner	ONE PALMER SQUARE SUITE 515, PRINCETON NJ 08542
Nimesh Shah	10 percent owner	12481 HIGH BLUFF DRIVE, SUITE 150, SAN DIEGO CA 92130
Marilyn R. Carlson	officer: Chief Medical Officer	C/O EVOKE PHARMA, INC., 505 LOMAS SANTA FE DRIVE, SOLANA BEACH CA 92075
Brian H Dovey	10 percent owner	ONE PALMER SQUARE, PRINCETON NJ 08542
Todd C Brady	director	C/O EVOKE PHARMA, INC., 505 LOMAS SANTA FE DRIVE, SOLANA BEACH CA 92075
Scott L Glenn	director
Lvpmc, Llc	10 percent owner	ONE EMBARCADERO CENTER SUITE 4050, SAN FRANCISCO CA 94111
Lvp Iii Partners Lp	10 percent owner	ONE EMBARCADERO CENTER SUITE 4050, SAN FRANCISCO CA 94111
Lvp Iii Associates, L.p.	10 percent owner	ONE EMBARCADERO CENTER SUITE 4050, SAN FRANCISCO CA 94111